GLEN BURNIE, Md., Oct. 12, 2017 -- Glen Burnie Bancorp (NASDAQ:GLBZ), parent company of The Bank of Glen Burnie®, announced that its Board of Directors declared a regular dividend of ten cents ($0.10) per share of common stock at their meeting on October 12, 2017. This action marks the company’s 101st consecutive dividend.
The regular dividend is payable on November 3, 2017 to shareholders of record at the close of business on October 23, 2017.
Glen Burnie Bancorp, parent company to The Bank of Glen Burnie, currently maintains consolidated assets totaling $389.8 million at September 30, 2017. Founded in 1949, The Bank of Glen Burnie is a community bank with eight branch offices serving Anne Arundel County, MD (www.thebankofglenburnie.com).
Certain information contained in this news release, which does not relate to historical financial information, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, which could cause the company’s actual results in the future to differ materially from its historical results and those presently anticipated or projected. For a more complete discussion of these and other risk factors, please see the company’s reports filed with the Securities and Exchange Commission.
Contact: Jeffrey D Harris, Chief Financial Officer
Email: [email protected]
Phone: 410-768-8883


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



